Evidence map›Paper›PMID 21900745›Full record

ArticleCell cycle (Georgetown, Tex.)2011

Linear polyubiquitin chains: a new modifier involved in NFκB activation and chronic inflammation, including dermatitis.

Kazuhiro Iwai

Open access · hybridAbstract read
In one paragraph

Article in Cell cycle (Georgetown, Tex.), 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 32 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Ubiquitin-proteasome signaling in lung injury.Translational research : the journal of laboratory and clinical medicine · 2018
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. HOIL-1L functions as the PKCζ ubiquitin ligase to promote lung tumor growth.American journal of respiratory and critical care medicine · 2014
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Assembly, analysis and architecture of atypical ubiquitin chains.Nature structural & molecular biology · 2013
    Article
  16. Article
  17. SHARPIN is a key regulator of immune and inflammatory responses.Journal of cellular and molecular medicine · 2012
    Review
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 3 countries.

Kazuhiro IwaiDepartment of Biophysics and Biochemistry, Graduate School of Medicine, Cell Biology and Metabolism Group, Graduate School of Frontier Biosciences, Osaka University, Osaka, Japan. kiwai@cellbio.med.osaka-u.ac.jp
Osaka University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The ubiquitin conjugation system regulates a wide variety of biological phenomena, including protein degradation and signal transduction, by regulating protein function via polyubiquitin conjugation in most cases. Several types of polyubiquitin chains exist in cells, and the type of polyubiquitin chain conjugated to a protein seems to determine how that protein is regulated. We identified a novel linear polyubiquitin chain and the ubiquitin-protein ligase complex that assembles it, designated LUBAC. Both were shown to have crucial roles in the canonical NFκB activation pathway. This year, three groups, including our laboratory, identified SHARPIN as a new subunit of LUBAC. Of great interest, Sharpin was identified as a causative gene of chronic proliferative dermatitis in mice (cpdm), which is characterized by numerous inflammatory symptoms including chronic dermatitis, arthritis and immune disorders. Deletion of SHARPIN drastically reduces the amount of LUBAC and attenuates signal-induced NFκB activation. The pleomorphic symptoms of cpdm mice suggest that LUBAC-mediated NFκB activation may play critical roles in mammals and be involved in various disorders. A forward look into the linear polyubiquitin research is also discussed.

Indexed as

AnimalsCarrier ProteinsChronic DiseaseDermatitisDNA RepairHepatocytesI-kappa B KinaseInflammationIntracellular Signaling Peptides and ProteinsMiceMice, KnockoutNF-kappa BPhosphorylationPolyubiquitinProtein BindingSignal TransductionCarrier ProteinsI-kappa B KinaseIkbkb protein, mouseIntracellular Signaling Peptides and ProteinsNEMO protein, mouseNF-kappa BPolyubiquitinRbck1 protein, mouseSipl1 protein, mouseUbiquitin-Protein Ligase ComplexesUbiquitin-Protein Ligases

Identifiers

PMID21900745
PMCPMC3218620
OpenAlexW2059670001

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.